New-look Education Portal online now
We are excited to share that our new-look Cổng thông tin giáo dục hiện đã có sẵn.
Going forward, you will be able to register for online and face-to-face events through the Education Portal.
Becoming an Education Portal member is a new way to support MVEC. Log in or create a profile, then add a paid membership.
Members get access to:
- past webinar recordings
- eLearnings
- special ticket prices for face-to-face MVEC events.
Please note: you will need an MVEC Education Portal free profile to register for our events, becoming a member is optional.
Visit the Cổng thông tin giáo dục now!
NT Independent: Free meningococcal B vaccination now available for infants, adolescents
Effective since 1 January 2025, a new vaccine program provides menB protection for infants aged 6 weeks to 2 years and adolescents aged 14 to 19 years.
NT Independent: Free meningococcal B vaccination now available for infants, adolescents
New MVEC RSV resources
MVEC has updated its respiratory syncytial virus (RSV) reference page to reflect the new National Immunisation Program (NIP) vaccine program.
From 3 February 2025, eligible pregnant women will be able to access the maternal RSV vaccine Abrysvo for free. The Australian Department of Health and Aged Care is also supporting national access to the monoclonal antibody Nirsevimab (brand name, Beyfortus) for newborns and young children at high risk of serious illness from RSV and where Abrysvo was not administered during pregnancy.
Read more about RSV and find links to helpful resources at MVEC: RSV.
Register for our CVU mini webinar on Wednesday 5 February for health professionals.
Cập nhật trang tham khảo tiêm chủng: Meningococcal
MVEC has updated its meningococcal reference page following the discontinuation of the Trumenba vaccine.
Along with information on meningococcal disease, epidemiology and prevention, the updated page includes new advice for those who have already started a primary course of Trumenba.
Immunisation Coalition 26th Annual Scientific Meeting: Register now
Các Immunisation Coalition’s 26quần què Annual Scientific Meeting will be held from Sunday 9 to Monday 10 February 2025.
Onsite spots are fully booked but registrations are still open for the ONLINE event.
Learn more and register on the Immunsation Coalition event page.
Vaccine education survey: Have your say!
Now that we are back, we want your input, insights Và feedback to ensure the educational content we provide meets your needs.
Please support our relaunch by completing this brief survey (3–5 minutes).
Coming soon: Immunisation Skills Workshop – Friday 28 March 2025
MVEC will be holding a half-day workshop focused in the areas of:
- promoting vaccine confidence
- how to have difficult conversations.
Ngày: Friday 28 March 2025
Thời gian: 8:00 am – 1:30 pm AEDT
Vị trí: Murdoch Children's Research Institute
Registrations will be opening soon
Learn more: MVEC: Immunisation Skills Workshop – Friday 28 March 2025.
Register now: CVU mini – Wednesday 5 February 2025 (webinar)
MVEC’s upcoming CVU mini will be on the topic of RSV preventative therapies.
This webinar offers healthcare professionals the opportunity to hear from leading experts on the latest in RSV prevention.
Hear from Prof Nigel Crawford, Dr Ingrid Laemmle-Ruff and Ms Rachael McGuire, followed by a brief Q&A session.
Ngày: Wednesday 5 February 2025
Thời gian: 6:00–7:00 pm AEDT
Vị trí: online (zoom link will be provided)
Phí đăng ký: free event
Learn more and register: MVEC: CVU mini – Wednesday 5 February 2025.
For more information about RSV, go to MVEC: Virus hợp bào hô hấp (RSV).
National Immunisation Program: New meningococcal vaccine funded from 1 July 2024
From 1 July 2024, the meningococcal ACWY vaccine MenQuadfi will be funded on the National Immunisation Program (NIP).
Invasive meningococcal disease (IMD) is caused by infection with the bacteria Neisseria meningitidis. It can result meningitis and septicaemia, as well as other infections like pneumonia, arthritis and conjunctivitis. Children under 2 years have the highest incidence of meningococcal disease in Australia, with another peak among adolescents and young adults aged 15 to 24 years.
MenQuadfi replaces Nimenrix for the adolescent age group (year 10 equivalent and up to 19 years for catch up). Children aged 12 months and those with specific medical conditions will continue to receive the Nimenrix vaccination on the NIP.
MenQuadfi was registered for use by the Therapeutic Goods Administration (TGA) in 2020. It is given as a single 0.5 mL dose, to be administered intramuscularly.
NIP: Meningococcal ACWY vaccines – updates for 1 July 2024
TGA: MenQuadfi
MVEC: Viêm não mô cầu
Victorian Department of Health: Changes to mpox vaccine eligibility criteria
Mpox is a viral zoonosis (an infection spread from animals to humans). Since April this year, there have been 24 confirmed cases of mpox in Victoria, 21 of which were locally acquired.
In Victoria, the eligibility criteria for free primary prevention vaccination (PPV) and post-exposure preventative vaccinations (PEPV) have been expanded.
Find out more about the recent transmission and accessing vaccines at Victorian Department of Health: Changes to mpox vaccine eligibility criteria.